BISTRO: BioImpedance Spectroscopy To maintain Renal Output Trial

Welcome to the BISTRO trial!

The BISTRO trial is a NIHR HTA funded pragmatic, multicentre randomised controlled trial (RCT) designed to test whether taking regular measurements with a bioimpedance device, which gives information about body composition, improves outcomes for people who have newly started haemodialysis treatment for kidney failure.

The BISTRO trial is based in the UK and has opened for recruitment on 6th April 2017.

We launched the BISTRO trial sites in several waves, starting in the first quarter of 2017. Currently 33 UK sites are participating. 

This website will be the central communication hub for all aspects of the trial. Feel free to browse the site and register your interest in participating if you haven’t done so already.

We will continue to add more information as the study progresses. Please contact us if you have any queries.

NEXT B‌ISTRO OPEN SURGERY CALLS:

5th Dec 2018 10.30-11.30

6th February 2019 10.30-11.30

27th March 2019 10.30-11.30

 

 

 

Best wishes,

The BISTRO trial team
NSTCCG.BISTRO@nhs.net

Last updated – 2018-12-04

BISTRO Recruitment NOVEMBER 2018:

Keele Clinical Trials Unit is committed to protecting the privacy and security of the personal information of all participants in our research.

For further information, please see the Keele University Privacy Notice for Research Participants.